Related Experiment Videos
RANTES and MCP-3 antagonists bind multiple chemokine receptors
J H Gong1, M Uguccioni, B Dewald
1Biomedical Research Centre, University of British Columbia, Vancouver, Canada.
The Journal of Biological Chemistry
|May 3, 1996
Summary
Chemokine antagonists targeting multiple cell migration pathways show promise. Truncated RANTES analogs effectively inhibited multiple chemokines, suggesting potential for broad-spectrum anti-inflammatory agents.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Chemokines regulate cell migration and inflammation.
- Targeting specific chemokines may be less effective than broad-spectrum antagonists.
Purpose of the Study:
- To identify multi-specific chemokine antagonists.
- To characterize truncated analogs of RANTES, MCP-3, and MCP-1.
Main Methods:
- Truncated chemokine analogs were synthesized.
- Binding affinity and cross-reactivity studies were performed using THP-1 cells.
- Inhibition of cell migration and enzyme release was assessed.
Main Results:
- RANTES (9-68) analog inhibited all three chemokines (RANTES, MCP-3, MCP-1) and their activities.
- MCP-3 (10-76) also showed broad cross-reactivity.
- NH2-terminal deletions influenced chemokine receptor specificity.
Conclusions:
- Truncated chemokine analogs can act as multi-specific antagonists.
- Design of high-affinity, multi-specific CC chemokine antagonists is feasible.
- This approach may offer improved control over cell migration and inflammation.